Differentiating non-lactating mastitis and malignant breast tumors by deep-learning based AI automatic classification system: A preliminary study

Objective To explore the application values of deep-learning based artificial intelligence (AI) automatic classification system, on the differential diagnosis of non-lactating mastitis (NLM) and malignant breast tumors, via its comparation with traditional ultrasound interpretations and the following interpretation conclusions made by the sonographers with various seniorities. Methods A total of 707 patients suffering from breast lesions (475 malignant breast tumors and 232 NLM), were selected from the following three medical centers, including Zhejiang Cancer Hospital, Hebei Province Hospital of Traditional Chinese Medicine, and Yantai Affiliated Hospital of Binzhou Medical University, and the time period was set from April 2020 to September 2021. All selected cases firstly accepted the routine breast ultrasound diagnosis, followed by the interpretations from a senior sonographer with more than 15 years of work experience, and an intermediate-aged sonographer with more than 5 years of work experience, independently. Meanwhile, a third physician also interpreted the same ultrasound images by deep learning–based AI automatic classification system, independent of the interpretation results from the previous two physicians. The kappa test was performed to evaluate the consistency between the conventional ultrasound interpretation results and pathological results interpreted from physicians with different working experiences. Results In total, 475 cases of malignant breast tumors (512 nodules) and 232 cases of NLM (255 nodules) were pathologically diagnosed. The accuracy, sensitivity, and specificity of conventional ultrasound interpretations vary from different sonographers with different working experiences. The accuracy, sensitivity, and specificity for intermediate-aged sonographers and senior sonographers were 76.92% (590/767), 84.71% (216/255), and 73.95% (374/512) and 87.35% (670/767), 86.27% (220/255), and 87.89% (450/512), respectively (P<0.001). In contrast, if the threshold was set as 0.5, the accuracy, sensitivity, and specificity from deep learning–based AI automatic classification system were 83.00%, 87.20%, and 85.33%, separately, and the area under the curve was 92.6. The results of the kappa consistency test indicated that the diagnosis results from the image interpretations by senior physicians and deep-learning based AI automatic classification system showed high consistency with postoperative pathological diagnosis results, and the kappa values are 0.72 and 0.71, respectively, with the P-value of less than 0.001. In contrast, the consistency between the image interpretation results from intermediate-aged physicians with less working experience, and postoperative pathological diagnosis results, seemed to be relatively lower, with a kappa value of only 0.53 and P-value of less than 0.001. Conclusions The deep learning–based AI automatic classification system is expected to become a reliable auxiliary way to distinguish NLM and malignant breast tumors due to its high sensitivity, accuracy, and specificity.

[1]  F. Xue,et al.  Dynamic Enhanced Magnetic Resonance Imaging versus Ultrasonic Diffused Optical Tomography in Early Diagnosis of Breast Cancer , 2022, Journal of healthcare engineering.

[2]  A. Dash,et al.  A Fine-tuned deep convolutional neural network for chest radiography image classification on COVID-19 cases , 2021, Multim. Tools Appl..

[3]  F. Beekman,et al.  Convolutional neural network based attenuation correction for 123I-FP-CIT SPECT with focused striatum imaging , 2021, Physics in medicine and biology.

[4]  M. Canpolat,et al.  Approaches to preclinical studies with heterogeneous breast phantom using reconstruction and three‐dimensional image processing algorithms for diffuse optical imaging , 2021, Int. J. Imaging Syst. Technol..

[5]  T. Mercan,et al.  Differentiation of tumoral and non‐tumoral breast lesions using back reflection diffuse optical tomography: A pilot clinical study , 2021, Int. J. Imaging Syst. Technol..

[6]  J. C. Ye,et al.  Development of digital breast tomosynthesis and diffuse optical tomography fusion imaging for breast cancer detection , 2020, Scientific Reports.

[7]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[8]  Mark A. Anastasio,et al.  Optimal breast cancer diagnostic strategy using combined ultrasound and diffuse optical tomography. , 2020, Biomedical optics express.

[9]  S. Ferrero,et al.  Idiopathic Granulomatous Mastitis: Etiopathogenetic Considerations on a Rare Benign Inflammatory Breast Disease , 2020, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[10]  Bradley J Erickson,et al.  A Survey of Deep-Learning Applications in Ultrasound: Artificial Intelligence-Powered Ultrasound for Improving Clinical Workflow. , 2019, Journal of the American College of Radiology : JACR.

[11]  L. Chen,et al.  [Granulomatous lobular mastitis: a clinicopathological analysis of 300 cases]. , 2019, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[12]  X. Cui,et al.  Artificial intelligence in breast ultrasound , 2019, World journal of radiology.

[13]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[14]  Melissa Matz,et al.  Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries , 2018, The Lancet.

[15]  N. C. Dornbluth,et al.  Idiopathic Granulomatous Mastitis: Manifestations at Multimodality Imaging and Pitfalls. , 2018, Radiographics : a review publication of the Radiological Society of North America, Inc.

[16]  Jingru Yan,et al.  Clinical application of automated breast ultrasound system in breast cancer screening and diagnosis , 2017 .

[17]  Shyam Visweswaran,et al.  Automated annotation and classification of BI-RADS assessment from radiology reports , 2017, J. Biomed. Informatics.

[18]  V. D’Orazi,et al.  Plasma Cell Mastitis in Men: A Single-center Experience and Review of the Literature. , 2016, In vivo.

[19]  G. Durhan,et al.  Imaging Findings in Patients with Granulomatous Mastitis , 2016, Iranian journal of radiology : a quarterly journal published by the Iranian Radiological Society.

[20]  C. Lehman,et al.  Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection. , 2015, JAMA internal medicine.

[21]  Maryellen L. Giger,et al.  Evaluation of clinical breast MR imaging performed with prototype computer-aided diagnosis breast MR imaging workstation: reader study. , 2011, Radiology.

[22]  E. Grant,et al.  Granulomatous lobular mastitis: imaging, diagnosis, and treatment. , 2009, AJR. American journal of roentgenology.

[23]  N. Nagaratnam,et al.  Plasma-Cell Mastitis , 1958, Postgraduate medical journal.